Brief: Mankind Pharma Q2 Consol Net Profit 5.12 Billion Rupees
06/11/2025 12:08
Nov 6 (Reuters) - Mankind Pharma MNKI.NS: MANKIND PHARMA Q2 CONSOL NET PROFIT 5.12 BILLION RUPEES MANKIND PHARMA Q2 CONSOL REVENUE FROM OPERATIONS 36.97 BILLION RUPEES Source text: [ID:] Further company coverage: MNKI.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery